Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela

Treatment Patterns of Care for Patients With Atrial Fibrillation In Venezuela

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02756481

Enrollment

Registered

2016-04-29

Start date

2013-10-31

Completion date

2014-11-30

Last updated

2016-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Valvular Atrial Fibrillation

Brief summary

To characterize treatment patterns and healthcare resource utilization among adults diagnosed with non-valvular atrial fibrillation (NVAF) from the private setting in Venezuela.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with diagnosis of AF (incident and prevalent cases) * Patient with at least 18 years * Patients enrolment before and during the study period * Patients treated in Venezuela

Exclusion criteria

* Women who were pregnant at any moment during the study period

Design outcomes

Primary

Measure	Time frame
Frequency of Hospitalization	approximately 2 years after enrollment
Duration of Hospitalization	approximately 2 years after enrollment
Frequency of Outpatient visits	approximately 2 years after enrollment

Secondary

Measure	Time frame
Frequency of Outpatient Visits due to Cerebrovascular Disease (CVD)	Up to 3 years
Incidence of Acute Myocardial Infarction (AMI)	Up to 3 years
Frequency of Hospitalization due to Acute Myocardial Infarction (AMI)	Up to 3 years
Duration of Hospitalization due to Acute Myocardial Infarction (AMI)	Up to 3 years
Frequency of Outpatient Visits due to Acute Myocardial Infarction (AMI)	Up to 3 years
Incidence of Systemic Embolism (SE)	Up to 3 years
Incidence of Cerebrovascular Disease (CVD)	Up to 3 years
Duration of Hospitalization due to Systemic Embolism (SE)	Up to 3 years
Frequency of Outpatient Visits due to Systemic Embolism (SE)	Up to 3 years
Incidence of Gastrointestinal Hemorrhage (GIH)	Up to 3 years
Frequency of Hospitalization due to Gastrointestinal Hemorrhage (GIH)	Up to 3 years
Duration of Hospitalization due to Gastrointestinal Hemorrhage (GIH)	Up to 3 years
Frequency of Outpatient Visits due to Gastrointestinal Hemorrhage (GIH)	Up to 3 years
Frequency of Hospitalization due to Systemic Embolism (SE)	Up to 3 years
Frequency of Hospitalization due to Cerebrovascular Disease (CVD)	Up to 3 years
Duration of Hospitalization due to Cerebrovascular Disease (CVD)	Up to 3 years

Outcome results